Description
TELJUST-AM Tablets (Telmisartan 40 mg + Amlodipine 5 mg) | Vin Medicament
Product Description
TELJUST-AM Tablets contain Telmisartan 40 mg and Amlodipine 5 mg, two medicines that help manage high blood pressure. Telmisartan belongs to a class of medicines called angiotensin II receptor blockers (ARBs), whereas Amlodipine is a calcium channel blocker. Together, these medicines work through different mechanisms to help lower blood pressure when prescribed by a qualified healthcare professional.
High blood pressure often does not cause noticeable symptoms. However, if it remains uncontrolled, it can increase the risk of serious cardiovascular complications. Therefore, appropriate medical assessment, regular blood pressure monitoring and adherence to a prescribed treatment plan are important.
Salt Composition
- Telmisartan: 40 mg
- Amlodipine: 5 mg
- Dosage Form: Tablet
- Brand Name: TELJUST-AM
- Therapeutic Category: Antihypertensive Combination
- Company: Vin Medicament
Uses and Indications
TELJUST-AM may be prescribed for the management of hypertension when combination treatment with Telmisartan and Amlodipine is considered appropriate. Telmisartan helps block the action of angiotensin II, a substance that narrows blood vessels. Consequently, blood vessels can relax and blood pressure can decrease.
Meanwhile, Amlodipine helps relax blood vessels by reducing calcium entry into vascular smooth muscle cells. As a result, the combination can help improve blood pressure control in suitable patients.
Nevertheless, treatment should be selected according to the patient’s blood pressure readings, medical history and other medicines. Do not start or change treatment without medical advice.
Product Features
- Contains Telmisartan 40 mg and Amlodipine 5 mg.
- Combines two antihypertensive medicines with different mechanisms of action.
- Intended for prescribed management of high blood pressure.
- Supports an individualised blood pressure treatment plan.
- Requires regular medical follow-up and blood pressure monitoring.
Precautions and Storage
Patients should inform their healthcare professional about kidney or liver problems, other medical conditions, allergies and all medicines they take. Telmisartan can harm an unborn baby; therefore, it must not be used during pregnancy. Consult a healthcare professional promptly if pregnancy occurs.
Possible side effects may include dizziness, ankle swelling or low blood pressure. In addition, patients should follow the approved product label for storage and administration instructions.
PCD Pharma Franchise and Distribution Opportunities
Vin Medicament offers pharmaceutical products for eligible wholesalers, distributors and PCD pharma franchise associates. Furthermore, interested businesses can contact Vin Medicament to enquire about product availability, distribution arrangements and applicable business terms.
All marketing and distribution activities must comply with applicable pharmaceutical regulations and approved product information.
Important Note
This content is for general product information and business reference only. Confirm the approved composition, indications, packaging and safety information from the official product label before publication. TELJUST-AM should be used only under the guidance of a qualified healthcare professional.
